Meyka Pro banner
Nexalin Technology, Inc.

Nexalin Technology, Inc. (NXL) Stock Overview

Explore Nexalin Technology, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NXL●NASDAQ
HealthcareMedical - Devices
$7.35
$3.004(69.06%)
U.S. Market is Open · 11:51

Nexalin Technology, Inc. (NXL)

Meyka AI Score

Z

Key Financials

Market Cap3.1M
P/E Ratio-0.29
EPS (TTM)$-0.47
ROE-2.78%
Fundamental Analysis

AI Price Forecasts

1 Month$4.53
3 Months$3.49
1 Year Target$1.19

NXL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Nexalin Technology, Inc. (NASDAQ: NXL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Nexalin Technology, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NXL on the NASDAQ shows an RSI of 53.82, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.19 for the NASDAQ listing.

Key metrics behind Nexalin Technology, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.29 and a market capitalization of 3.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NXL on the NASDAQ.

Price Performance (NASDAQ: NXL)

1-Day Change
-1.61%
5-Day Change
-2.51%
1-Month Change
-42.93%
3-Month Change
-56.77%
6-Month Change
-59.58%
Year-to-Date (YTD) Change
-74.43%
1-Year Change
-84.45%
3-Year Change
-65.62%
5-Year Change
-93.66%
All-Time (Max) Change
-93.66%

Contact Information

713 660 1100
1776 Yorktown, Houston, TX, 77056

Company Facts

80 Employees
IPO DateSep 16, 2022
CountryUS
Actively Trading

Frequently Asked Questions